A randomized trial that tracked adults for 4.5 years found that people assigned to use sunscreen every day showed no measurable increase in skin aging over the study period — while people who used it only when they thought to showed a detectable rise. By the end of the trial, skin aging was 24% lower in the daily-sunscreen group than in the occasional-use group.
In brief:
- In a randomized trial, daily sunscreen use was linked to 24% less skin aging over 4.5 years compared with discretionary use, with no detectable aging increase in the daily group at all.
- A separate study estimated that sun exposure accounts for about 80% of visible facial aging signs — mainly wrinkles, texture, and pigmentation — while sagging tracks age itself more than sun history.
- Sunscreen's effect in these studies is prevention going forward, not a reversal of damage that's already there.
What did the sunscreen trial actually test?
Hughes and colleagues ran a community-based randomized trial in Nambour, Australia — a subtropical town at latitude 26° south, with intense year-round sun. Out of 1,621 adults randomly selected from the local community register, 903 adults younger than 55 were randomized into one of four groups, crossing two factors: daily use of broad-spectrum sunscreen versus discretionary use (applying it only when they chose to), and a daily 30 mg beta-carotene supplement versus a placebo pill.
Researchers measured skin aging using microtopography — a technique that takes a detailed impression of skin surface texture — comparing results from 1992 to 1996, a 4.5-year follow-up. The assessors grading the images didn't know which group each person belonged to.
How much difference did daily sunscreen make?
A real one. People in the daily-sunscreen group showed no detectable increase in skin aging over the full 4.5 years. People in the discretionary-use group did show a measurable increase, and when the two groups were compared directly, the daily users ended up with 24% lower odds of increased skin aging than the discretionary users (relative odds 0.76, 95% confidence interval 0.59 to 0.98). The beta-carotene supplement, on the other hand, made no overall difference to skin aging in either sunscreen group.
How much of skin aging is actually caused by the sun?
A separate study gives a sense of scale. Flament and colleagues studied 298 Caucasian women between ages 30 and 78, dividing them into a "sun-seeking" group and a "sun-phobic" group based on a dermatologist's assessment of their lifetime sun exposure, then had trained experts grade 22 clinical signs of aging against standardized photographic scales. Wrinkles, skin texture, and pigmentation irregularities were all more common in the sun-seeking group at every age studied — but sagging (the technical term is ptosis) tracked chronological age about equally in both groups, and blood-vessel changes showed no clear pattern with age at all. Taken together, the researchers estimated that UV exposure accounts for roughly 80% of visible facial aging signs — a figure specific to the wrinkle, texture, and pigmentation changes that sun exposure clearly drove, not every sign of aging a face can show.
What the research says
Hughes and colleagues, following 903 adults in a randomized, placebo-controlled community trial over 4.5 years, found no detectable increase in skin aging among people assigned to daily sunscreen use, versus a measurable increase among those assigned to discretionary use — a 24% lower relative odds of increased aging in the daily-use group (relative odds 0.76, 95% CI 0.59–0.98).¹ Separately, Flament and colleagues, comparing 298 Caucasian women with high versus low lifetime sun exposure, found sun exposure history tracked closely with wrinkles, texture, and pigmentation changes, and estimated that UV exposure accounts for about 80% of visible facial aging signs.²
Two limits apply. The sunscreen trial's own authors note that some outcome data were missing and that the study had only modest power to detect moderate-sized effects — a true benefit smaller than what they found could have gone undetected, not the other way around; it was also conducted in a high-UV subtropical setting, so the exact size of the effect may not transfer directly to a lower-sun climate, even if the underlying mechanism does. The sun-exposure study is cross-sectional and relies on a dermatologist's retrospective grading of lifetime sun history rather than a randomized assignment, so while it's a useful estimate of how much sun exposure contributes to visible aging signs across a population, it can't isolate any one person's individual risk.
What you can do this week
- Treat sunscreen as a daily habit, not a beach-day item. The trial that found a measurable benefit used daily, broad-spectrum sunscreen — applied regardless of the weather or whether a beach trip was on the calendar.
- Expect prevention, not reversal. Both studies measured whether sunscreen slowed new skin aging going forward; neither tested whether it undoes wrinkles, texture, or pigmentation changes that already exist.
- If sun damage has already left rough texture or fine lines, ask about options. Pallas prescribes compounded tretinoin cream when a US-licensed clinician decides it's appropriate.
The headline finding here isn't dramatic — nobody's skin got younger. What the trial shows is that a plain daily habit measurably slowed a process that, left alone, kept moving.
